<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font8" size="10" family="Giovanni,Bold" color="#000000"/>
	<fontspec id="font9" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="110" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Nuclear Receptor 2005, 3 :4<i>Nuclear Receptor</i></text>
<text top="41" left="370" width="184" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.nuclear-receptor.com/content/3/1/4</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="95" segment_no="27" tag_type="text">Page 6 of 7<b>3</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="96" segment_no="28" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="56" height="10" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Conclusion</text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t6" reading_order_no="3" segment_no="4" tag_type="text">We have confirmed the potential importance of genetic</text>
<text top="110" left="55" width="241" height="9" font="font5" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="text">variation at the PPARA locus in modulating susceptibility<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="text">to cardiovascular disease, and have shown that this asso-<b>Conclusion</b></text>
<text top="134" left="55" width="225" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">ciation is relevant to individuals with type 2 diabetes.</text>
<text top="157" left="55" width="43" height="10" font="font4" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="title">Methods</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">In the Tayside region of Scotland detailed clinical infor-<i>PPARA </i></text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="6" tag_type="text">mation on all individuals with diabetes mellitus is</text>
<text top="192" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">recorded on a continuously updated electronic clinical</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="6" tag_type="text">information system known as DARTS (Diabetes Audit and</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="6" tag_type="text">Research in Tayside Scotland) [16]. Validated, region-<b>Methods</b></text>
<text top="228" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">wide electronic record-linkage techniques facilitate the</text>
<text top="239" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">identification of individuals with diabetes in the Tayside</text>
<text top="251" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="6" tag_type="text">population with a sensitivity of 97% [16]. Relevant clini-</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="6" tag_type="text">cal data is linked to databases containing all inpatient</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="6" tag_type="text">hospital admissions in Tayside from 1980 with diagnostic<a href="">[16]. </a>Validated, region-</text>
<text top="286" left="55" width="241" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">codes from ICD-9/10 (International Classification of Dis-</text>
<text top="298" left="55" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">eases, ninth and tenth revisions), and records of death cer-</text>
<text top="310" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">tificates from the registrar general. This automated<a href="">97% [16]</a>. Relevant clini-</text>
<text top="322" left="55" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">electronic follow-up is manually validated through a con-</text>
<text top="333" left="55" width="241" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">tinuous cycle of review by dedicated study clinicians. Inci-</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">dent cardiovascular events in this population have been</text>
<text top="357" left="55" width="109" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">described previously [27].</text>
<text top="380" left="55" width="241" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="7" tag_type="text">Following written informed consent from individuals reg-</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="7" tag_type="text">istered on DARTS, blood samples for genetic studies have</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="7" tag_type="text">been collected, thereby creating a genetic sub-study</text>
<text top="416" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="7" tag_type="text">known as Go-DARTS. Rigorous compliance with NHS</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="7" tag_type="text">data protection and encryption standards is maintained<a href="">eviously [27].</a></text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="7" tag_type="text">and the study was approved by the local research ethics</text>
<text top="451" left="55" width="48" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="7" tag_type="text">committee.</text>
<text top="472" left="55" width="242" height="13" font="font5" id="p1_t35" reading_order_no="32" segment_no="12" tag_type="text">The PPAR α L162V and G2528C genotypes were deter-</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="12" tag_type="text">mined in 1,810 individuals all of whom were Caucasian</text>
<text top="498" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="12" tag_type="text">with type 2 diabetes diagnosed between the age of 35 and</text>
<text top="510" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="12" tag_type="text">70 years. Taqman (Applied Biosystems) allelic discrimina-</text>
<text top="521" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="12" tag_type="text">tion assays were used. The primers and probes used for the</text>
<text top="533" left="55" width="241" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="12" tag_type="text">allelic discrimination assays were as follows: L162V For-</text>
<text top="545" left="55" width="241" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="12" tag_type="text">ward primer-CAGAAACAAATGCCAGTATTGTCG, Reverse</text>
<text top="557" left="55" width="241" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="12" tag_type="text">primer-GGCCACCTTACCTACCGTTGTG, L162 probe</text>
<text top="568" left="55" width="241" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="12" tag_type="text">(FAM labelled) – TTCACAAGTGCCTTTCTGTCG-</text>
<text top="580" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="12" tag_type="text">GGATGT, V162 probe (TET labelled) – TTCACAAGT-</text>
<text top="592" left="55" width="116" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="12" tag_type="text">GCGTTTCTGTCGGGATGT.</text>
<text top="615" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="19" tag_type="text">G2528C Forward primer-TCCTTAAATATGGT-</text>
<text top="627" left="55" width="241" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="19" tag_type="text">GGAACACTTGAAG, Reverse primer-TCACAACCAC-</text>
<text top="639" left="55" width="241" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="19" tag_type="text">CAGTTTTGCAT, G2528 probe (FAM labelled) –</text>
<text top="651" left="55" width="241" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="19" tag_type="text">ATATCTAGTTT G GATTCAAAAGCTTCATTTCCCA, C2528</text>
<text top="662" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="19" tag_type="text">probe (TET labelled) – ATATCTAGTTT C GAT-</text>
<text top="674" left="55" width="118" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="19" tag_type="text">TCAAAAGCTTCATTTCCCA.</text>
<text top="698" left="55" width="37" height="9" font="font9" id="p1_t52" reading_order_no="49" segment_no="23" tag_type="title">Statistics</text>
<text top="709" left="55" width="241" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="25" tag_type="text">For each clinical measure the mean was determined from</text>
<text top="721" left="55" width="241" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="25" tag_type="text">multiple measures obtained up to a maximum period of</text>
<text top="87" left="313" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="3" tag_type="text">three years (up to two years prior to enrolment, and up to</text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">one year following enrolment). LDL cholesterol was esti-</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">mated through the use of the Freidwald equation. Linear<b>G</b></text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">regression was used to determine the association of geno-</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">type with each measure corrected for age at genotyping.</text>
<text top="145" left="313" width="241" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">For determining the association of genotype with age of<b>C</b></text>
<text top="157" left="313" width="241" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">diagnosis, this was corrected for gender and presence of a</text>
<text top="169" left="313" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">history of smoking by determining residuals and adding</text>
<text top="181" left="313" width="241" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">these to the overall mean age of diagnosis. Cox's propor-<i><b>Statistics</b></i></text>
<text top="192" left="313" width="241" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">tional hazards was used to model time to first event. All</text>
<text top="204" left="313" width="241" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">individuals were followed from the point of genotyping</text>
<text top="216" left="313" width="241" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">until a non-fatal myocardial infarction occurred, or a</text>
<text top="228" left="313" width="241" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">composite of non-fatal myocardial infarct or all cause</text>
<text top="239" left="313" width="241" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">death. Censoring occurred either at the end of the study or</text>
<text top="251" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="3" tag_type="text">death from any cause. Both variants were included in the</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="3" tag_type="text">model and it was found that a co-dominant model for</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="3" tag_type="text">each variant produced the best fit. The following variables</text>
<text top="286" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="3" tag_type="text">were also included in the model; age at genotyping, gen-</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="3" tag_type="text">der, history of smoking, treatment with insulin, a previous</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="3" tag_type="text">history of a myocardial infarction, prevalent angina and</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t75" reading_order_no="72" segment_no="3" tag_type="text">prevalent cerebrovascular disease. Haplotype frequency</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t76" reading_order_no="73" segment_no="3" tag_type="text">estimates together with haplotype effects were determined</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="3" tag_type="text">using the THESIAS Program [28,29]. In the case of survival</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="3" tag_type="text">analysis by haplotype using THESIAS only age at genotyp-</text>
<text top="369" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="3" tag_type="text">ing, prevalent angina and a previous history of a myocar-</text>
<text top="380" left="313" width="181" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="3" tag_type="text">dial infarction were included in the model.</text>
<text top="404" left="313" width="102" height="10" font="font4" id="p1_t81" reading_order_no="78" segment_no="8" tag_type="title">List of abbreviations</text>
<text top="416" left="313" width="224" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="9" tag_type="text">DARTS Diabetes Audit and Research in Tayside Study</text>
<text top="439" left="313" width="127" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="10" tag_type="text">Go-DARTS Genetics of DARTS</text>
<text top="460" left="313" width="238" height="13" font="font5" id="p1_t84" reading_order_no="81" segment_no="11" tag_type="text">PPAR α Peroxisome Proliferator Activated Receptor alpha</text>
<text top="484" left="313" width="100" height="13" font="font6" id="p1_t85" reading_order_no="82" segment_no="13" tag_type="text">PPARA Gene for PPAR α</text>
<text top="507" left="313" width="100" height="13" font="font6" id="p1_t86" reading_order_no="83" segment_no="14" tag_type="text">PPARD Gene for PPAR δ</text>
<text top="533" left="313" width="118" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="15" tag_type="text">CVD Cardiovascular disease</text>
<text top="557" left="313" width="184" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="16" tag_type="text">LOCAT Lopoid Coronary Angiography Trial<a href="">[28,29]. </a>In the case of survival</text>
<text top="580" left="313" width="185" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="17" tag_type="text">NPHS2 Second Northwick Park Heart Study</text>
<text top="604" left="313" width="72" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="18" tag_type="text">HR Hazard Ratio</text>
<text top="627" left="313" width="96" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="20" tag_type="text">CI Confidence Interval</text>
<text top="651" left="313" width="103" height="10" font="font4" id="p1_t92" reading_order_no="89" segment_no="21" tag_type="title">Competing interests<b>List of abbreviations</b></text>
<text top="662" left="313" width="241" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="22" tag_type="text">The author(s) declare that they have no competing inter-</text>
<text top="674" left="313" width="18" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="22" tag_type="text">ests.</text>
<text top="698" left="313" width="114" height="10" font="font4" id="p1_t95" reading_order_no="92" segment_no="24" tag_type="title">Authors' contributions</text>
<text top="709" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="26" tag_type="text">ASFD and CNAP wrote the manuscript and performed the</text>
<text top="721" left="313" width="241" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="26" tag_type="text">analysis, CNAP and ADM conceived the study and partic-</text>
</page>
</pdf2xml>
